Ironwood Pharmaceuticals logo

Ironwood Pharmaceuticals share price today

(IRWD)

Ironwood Pharmaceuticals share price is $4.59 & ₹391.39 as on 27 Dec 2024, 2.30 'hrs' IST

$4.59

▲

-0.02

(-0.43%)

Market is closed - opens 8 PM, 27 Dec 2024

View live Ironwood Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Ironwood Pharmaceuticals from India. Also see the sentimental analysis on Indian investors investing in Ironwood Pharmaceuticals. Get details on the Indian mutual funds that are investing in Ironwood Pharmaceuticals. Get Analyst recommendations and forecasts along with all the Ironwood Pharmaceuticals's financials.

Ironwood Pharmaceuticals share price movements

  • Today's Low: $4.31
    Today's High: $4.66

    Day's Volatility :7.52%

  • 52 Weeks Low: $3.06
    52 Weeks High: $15.70

    52 Weeks Volatility :80.51%

Ironwood Pharmaceuticals Returns

PeriodIronwood Pharmaceuticals, Inc.Sector (Health Care)Index (Russel 2000)
3 Months
14.18%
-8.8%
0.0%
6 Months
-29.6%
-4.3%
0.0%
1 Year
-59.98%
2.7%
0.0%
3 Years
-61.17%
-0.8%
-21.8%

Ironwood Pharmaceuticals Key Statistics

in dollars & INR

Previous Close
$4.61
Open
$4.58
Today's High
$4.655
Today's Low
$4.305
Market Capitalization
$737.7M
Today's Volume
$859.0K
52 Week High
$15.7
52 Week Low
$3.06
Revenue TTM
$378.4M
EBITDA
$97.4M
Earnings Per Share (EPS)
$-0.01
Profit Margin
-0.65%
Quarterly Earnings Growth YOY
-0.77%
Return On Equity TTM
-574.72%

How to invest in Ironwood Pharmaceuticals from India?

It is very easy for Indian residents to invest directly in Ironwood Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Ironwood Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Ironwood Pharmaceuticals or IRWD on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Ironwood Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Ironwood Pharmaceuticals shares which would translate to 0.186 fractional shares of Ironwood Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Ironwood Pharmaceuticals, in just a few clicks!

Returns in Ironwood Pharmaceuticals for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Ironwood Pharmaceuticals investment value today

Current value as on today

₹42,535

Returns

₹57,465

(-57.47%)

Returns from Ironwood Pharmaceuticals Stock

₹59,983 (-59.98%)

Dollar Returns

₹2,518 (+2.52%)

Indian investors sentiment towards Ironwood Pharmaceuticals

13%

Period: Sep 27, 2024 to Dec 26, 2024. Change in 30 Days versus previous period

Search volume for Ironwood Pharmaceuticals on INDmoney from India has grown in the last 30 days as on Dec 27, 2024. 13% more investors are searching Ironwood Pharmaceuticals in the last 30 days versus the previous period.

Global Institutional Holdings in Ironwood Pharmaceuticals

  • BlackRock Inc

    14.30%

  • Vanguard Group Inc

    13.77%

  • Sarissa Capital Management LP

    10.24%

  • Pacer Advisors, INC.

    7.05%

  • State Street Corp

    6.20%

  • Renaissance Technologies Corp

    5.37%

Analyst Recommendation on Ironwood Pharmaceuticals

Buy

    91%Buy

    8%Hold

    0%Sell

Based on 12 Wall street analysts offering stock ratings for Ironwood Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 12 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
11
11
11
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Ironwood Pharmaceuticals

What analysts predicted

Upside of 172.33%

Current:

$4.59

Target:

$12.50

Insights on Ironwood Pharmaceuticals

  • Price Movement

    In the last 1 month, IRWD stock has moved up by 25.1%

  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 94.39M → 91.59M (in $), with an average decrease of 3.0% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, -4.16M → 31.09M (in $), with an average increase of 243.4% per quarter

  • IRWD vs HLN (1 yr)

    In the last 1 year, Haleon Plc Spon Ads has given 17.6% return, outperforming this stock by 77.7%

  • Price to Sales

    ForIRWD every $1 of sales, investors are willing to pay $1.9, whereas for Haleon Plc Spon Ads, the investors are paying $4.0 for every $1 of sales.

Ironwood Pharmaceuticals Financials in INR & Dollars

FY18Y/Y Change
Revenue
$346.6M
↑ 16.21%
Net Income
$-282.4M
↑ 141.47%
Net Profit Margin
-81.46%
↓ 42.26%
FY19Y/Y Change
Revenue
$428.4M
↑ 23.59%
Net Income
$-15.3M
↓ 94.58%
Net Profit Margin
-3.57%
↑ 77.89%
FY20Y/Y Change
Revenue
$389.5M
↓ 9.08%
Net Income
$106.2M
↓ 793.33%
Net Profit Margin
27.26%
↑ 30.83%
FY21Y/Y Change
Revenue
$413.8M
↑ 6.22%
Net Income
$528.4M
↑ 397.71%
Net Profit Margin
127.72%
↑ 100.46%
FY22Y/Y Change
Revenue
$410.6M
↓ 0.76%
Net Income
$175.1M
↓ 66.87%
Net Profit Margin
42.64%
↓ 85.08%
FY23Y/Y Change
Revenue
$442.7M
↑ 7.83%
Net Income
$-1.0B
↓ 672.5%
Net Profit Margin
-226.37%
↓ 269.01%
Q2 FY23Q/Q Change
Revenue
$107.4M
↑ 3.19%
Net Income
$-1.1B
↓ 2423.55%
Net Profit Margin
-989.17%
↓ 1033.1%
Q3 FY23Q/Q Change
Revenue
$113.7M
↑ 5.92%
Net Income
$15.3M
↓ 101.44%
Net Profit Margin
13.47%
↑ 1002.64%
Q4 FY23Q/Q Change
Revenue
$117.6M
↑ 3.35%
Net Income
$-1.1M
↓ 107.09%
Net Profit Margin
-0.92%
↓ 14.39%
Q1 FY24Q/Q Change
Revenue
$74.9M
↓ 36.3%
Net Income
$-4.2M
↑ 282.89%
Net Profit Margin
-5.56%
↓ 4.64%
Q2 FY24Q/Q Change
Revenue
$94.4M
↑ 26.07%
Net Income
$-860.0K
↓ 79.34%
Net Profit Margin
-0.91%
↑ 4.65%
Q3 FY24Q/Q Change
Revenue
$91.6M
↓ 2.97%
Net Income
$31.1M
↓ 3715.35%
Net Profit Margin
33.95%
↑ 34.86%
FY18Y/Y Change
Profit
$313.9M
↑ 12.56%
FY19Y/Y Change
Profit
$404.5M
↑ 28.88%
FY20Y/Y Change
Profit
$386.4M
↓ 4.49%
FY21Y/Y Change
Profit
$412.2M
↑ 6.69%
FY22Y/Y Change
Profit
$409.2M
↓ 0.74%
FY23Y/Y Change
Profit
$441.2M
↑ 7.82%
Q2 FY23Q/Q Change
Profit
$107.1M
↑ 3.22%
Q3 FY23Q/Q Change
Profit
$113.2M
↑ 5.71%
Q4 FY23Q/Q Change
Profit
$117.0M
↑ 3.36%
Q1 FY24Q/Q Change
Profit
$74.4M
↓ 36.46%
Q2 FY24Q/Q Change
Profit
$93.9M
↑ 26.26%
Q3 FY24Q/Q Change
Profit
$91.6M
↓ 2.45%
FY18Y/Y Change
Operating Cash Flow
$-70.9M
↓ 28.81%
Investing Cash Flow
$88.9M
↓ 41.33%
Financing Cash Flow
$30.1M
↑ 51.61%
FY19Y/Y Change
Operating Cash Flow
$10.7M
↓ 115.13%
Investing Cash Flow
$-11.1M
↓ 112.54%
Financing Cash Flow
$-1.2M
↓ 103.94%
FY20Y/Y Change
Operating Cash Flow
$168.8M
↑ 1474.23%
Investing Cash Flow
$-1.8M
↓ 83.47%
Financing Cash Flow
$18.5M
↓ 1665.06%
FY21Y/Y Change
Operating Cash Flow
$261.9M
↑ 55.12%
Investing Cash Flow
$-265.0K
↓ 85.61%
Financing Cash Flow
$-4.6M
↓ 124.53%
FY22Y/Y Change
Operating Cash Flow
$273.8M
↑ 4.53%
Investing Cash Flow
$-136.0K
↓ 48.68%
Financing Cash Flow
$-237.6M
↑ 5120.95%
Q2 FY23Q/Q Change
Operating Cash Flow
$35.0M
↓ 56.39%
Investing Cash Flow
$-999.5M
↑ 7688300.0%
Financing Cash Flow
$399.1M
↑ 9924.39%

Ironwood Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Ironwood Pharmaceuticals is currently in a neutral trading position according to technical analysis indicators.

Ironwood Pharmaceuticals Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Ironwood Pharmaceuticals, Inc.
Ironwood Pharmaceuticals, Inc.
25.07%
-29.6%
-59.98%
-61.17%
-65.59%
Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc.
9.83%
0.99%
5.21%
64.09%
29.74%
Haleon Plc Spon Ads
Haleon Plc Spon Ads
0.21%
17.92%
17.63%
31.44%
31.44%
Zoetis Inc.
Zoetis Inc.
-6.35%
-4.52%
-16.05%
-32.23%
25.19%
Viatris Inc.
Viatris Inc.
-4.99%
18.16%
15.76%
-7.92%
-23.13%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Ironwood Pharmaceuticals, Inc.
Ironwood Pharmaceuticals, Inc.
58.25
NA
-0.26
0.18
-5.75
0.13
NA
-1.95
Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc.
37.07
37.07
0.32
6.37
0.16
0.12
NA
26.87
Haleon Plc Spon Ads
Haleon Plc Spon Ads
29.52
29.52
1.76
0.34
0.07
0.04
0.02
1.82
Zoetis Inc.
Zoetis Inc.
31.17
31.17
2.56
5.88
0.47
0.15
0.01
11.59
Viatris Inc.
Viatris Inc.
224.4
NA
0.07
2.69
-0.04
0.02
0.04
16.58
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Ironwood Pharmaceuticals, Inc.
Ironwood Pharmaceuticals, Inc.
Buy
$737.7M
-65.59%
58.25
-0.65%
Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc.
Buy
$14.1B
29.74%
37.07
17.21%
Haleon Plc Spon Ads
Haleon Plc Spon Ads
Buy
$44.0B
31.44%
29.52
10.75%
Zoetis Inc.
Zoetis Inc.
Buy
$74.7B
25.19%
31.17
26.55%
Viatris Inc.
Viatris Inc.
Hold
$14.8B
-23.13%
224.4
-5.87%

About Ironwood Pharmaceuticals

ironwood pharmaceuticals (nasdaq: irwd) is focused on creating medicines that make a difference for patients, building value to earn the continued support of our fellow shareholders, and empowering our passionate team to keep doing these two things again and again as we continue to build a leading gastrointestinal therapeutics company. we discovered, developed and are commercializing a medicine for the treatment of adults suffering from irritable bowel syndrome with constipation (ibs-c) or chronic idiopathic constipation (cic). we are also developing a rich pipeline of programs seeking to address patient needs across the upper and lower gastrointestinal tract. our pipeline priorities include exploring further opportunities for our lead medicine, as well as leveraging our therapeutic expertise in gastrointestinal disorders and our pharmacologic expertise in guanylate cyclases to advance multiple investigational medicines. ironwood was founded in 1998 out of the whitehead institute for b
Organization
Ironwood Pharmaceuticals
Employees
267
CEO
Mr. Thomas A. McCourt
Industry
Health Technology

Management People of Ironwood Pharmaceuticals

NameTitle
Mr. Thomas A. McCourt
CEO & Director
Mr. Sravan Kumar Emany
Senior VP, CFO & COO
Mr. John Minardo
Senior VP, Chief Legal Officer & Secretary
Dr. Michael Shetzline M.D., Ph.D.
Chief Medical Officer, Senior VP and Head of Research & Drug Development
Mr. Ronald Silver
Corporate Controller & Principal Accounting Officer
Dr. Rosario Lobrutto M.B.A., M.S., Ph.D.
VP & Global Head of Technical Operations
Mr. Greg Martini
Vice President of Strategic Finance & Investor Relations
Ms. Beth Calitri
VP of Corporate Communications & Media Relations
Mr. Mike Nanfito
Vice President of Sales & Sales Excellence
Dr. Susanna Y. Huh M.D., M.P.H.
VP & Head of Clinical Development

Important FAQs about investing in Ironwood Pharmaceuticals from India :

What is Ironwood Pharmaceuticals share price today?

Ironwood Pharmaceuticals share price today stands at $4.59, Open: $4.58 ; Previous Close: $4.61 ; High: $4.66 ; Low: $4.31 ; 52 Week High: $15.70 ; 52 Week Low: $3.06. The stock opens at $4.58, after a previous close of $4.61. The stock reached a daily high of $4.66 and a low of $4.31, with a 52-week high of $15.70 and a 52-week low of $3.06.

Can Indians buy Ironwood Pharmaceuticals shares?

Yes, Indians can invest in the Ironwood Pharmaceuticals (IRWD) from India.

With INDmoney, you can buy Ironwood Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Ironwood Pharmaceuticals at zero transaction cost.

How can I buy Ironwood Pharmaceuticals shares from India?

It is very easy to buy Ironwood Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Ironwood Pharmaceuticals be purchased?

Yes, you can buy fractional shares of Ironwood Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Ironwood Pharmaceuticals stocks?

To start investing in Ironwood Pharmaceuticals, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Ironwood Pharmaceuticals

Today’s highest price of Ironwood Pharmaceuticals (IRWD) is $4.66.

Today’s lowest price of Ironwood Pharmaceuticals (IRWD) is $4.31.

What is today's market capitalisation of Ironwood Pharmaceuticals

Today's market capitalisation of Ironwood Pharmaceuticals IRWD is 737.7M

What is the 52 Week High and Low Range of Ironwood Pharmaceuticals

  • 52 Week High

    $15.70

  • 52 Week Low

    $3.06

What are the historical returns of Ironwood Pharmaceuticals?

  • 1 Month Returns

    25.07%

  • 3 Months Returns

    -29.6%

  • 1 Year Returns

    -59.98%

  • 5 Years Returns

    -65.59%

Who is the Chief Executive Officer (CEO) of Ironwood Pharmaceuticals

Mr. Thomas A. McCourt is the current Chief Executive Officer (CEO) of Ironwood Pharmaceuticals.